Sign inSign up
Back to all events
Join investors at the
237th Healthcare Investors Alliance
Group video call | 25th September 2025
Apply
237th Healthcare Investors Alliance
Healthcare
About event

The Healthcare Investors’ Alliance will take place on September 25th, 2025, bringing together over 30 senior leaders from family offices, private investment firms, and institutional funds with an active focus on healthcare.

 

This private video-call gathering offers a focused environment for healthcare investors to exchange insights, identify emerging opportunities and align on strategies to navigate today’s fast-evolving market. From breakthrough technologies to scalable care delivery models, participants will examine what defines a future leader in the sector and how capital can accelerate their success.

 

Participants will:

 

  • Explore where capital is flowing across biotech, medtech, digital health, and wellness
  • Discuss strategies for evaluating scalability, clinical traction, and regulatory outlook
  • Share perspectives on market timing, impact, and the next generation of investable healthcare ventures
  • Engage in one-to-one meetings with peers to foster alignment and potential co-investment
     


The agenda of the gathering:

 

  • A roundtable discussion with all investors on the investment strategies VCs should adopt to navigate economic downturns while still backing innovation in healthcare

  • A peer-led dialogue around key signals in innovation, regulation, and market demand

  • One-to-one meetings for deeper conversations and strategic follow-up
     


Every Investors Alliance session is a focused, time-efficient gathering built around quality over quantity, connecting serious investors with relevant opportunities in a trusted setting.


Held via video group call on September 25, 2025, the session runs for 3 hours
(6–9 PM Dubai / 10 AM –1 PM New York / 4–7 PM Zurich time / 7 - 10 AM California time).

Participants

CEO and Co-founder
PiroGon
CEO
Auctus Surgical
Executive
MedConnect AI Solutions
VP & COO
Surgibox
COO
AlignRight.AI
CEO
Cerhum
President/CEO
Accufix Holdings Inc.
CEO
Arphamid Therapeutics
Founder - CSO
Equaly
Co-Founder
thevirtualpmo limited
Managing Director
SpringRock Ventures
Managing Partner
Greater Ventures
Investment Director
IBB Ventures
Senior Venture Partner
Global Health Impact Funds
Founder and Managing Partner
New Dimensions Health Fund
Managing Director
Bridge Street Capital
Head of VC
Corundum Systems Biology
Investor
Investor
Investment Director Life Sciences
Brandenburg Kapital GmbH
Founder and Managing Partner
Endeavour Vision
Investor
Two Sigma Ventures
Board Advisor
DataVaccinator
Founder & CEO
Xerion Investments
Director Of Strategic Partnerships
IQVIA
General Partner
Northlea Partners LLLP
CEO
Limitless Earth PLC
Founder
Diginova Health Solutions
Managing Director
Future Potential Management
Founding Partner
Global Sustainability Impact Fund, LLC
Chairman and CEO
Summer Atlantic Capital
President & CEO
The Cannaregio Group
Managing Partner
Indite Ventures LLP
Founder
Inhite Ventures
Managing Director & CEO
Caason Group
Managing Director
AKS Family Partners LP
Request Meetings

Investors

Endeavour Vision
Founder and Managing Partner
Corundum Systems Biology
Head of VC
Bridge Street Capital
Managing Director
Brandenburg Kapital GmbH
Investment Director Life Sciences
Greater Ventures
Managing Partner
Global Health Impact Funds
Senior Venture Partner
SpringRock Ventures
Managing Director
IBB Ventures
Investment Director
New Dimensions Health Fund
Founder and Managing Partner
DataVaccinator
Board Advisor
Two Sigma Ventures
Investor
Northlea Partners LLLP
General Partner
Limitless Earth PLC
CEO
IQVIA
Director Of Strategic Partnerships
Xerion Investments
Founder & CEO
Diginova Health Solutions
Founder
Global Sustainability Impact Fund, LLC
Founding Partner
Future Potential Management
Managing Director
Summer Atlantic Capital
Chairman and CEO
The Cannaregio Group
President & CEO
Indite Ventures LLP
Managing Partner
Inhite Ventures
Founder
Caason Group
Managing Director & CEO
AKS Family Partners LP
Managing Director
Investment topics

Projects

Accufix Surgical
Healthcare
Equaly Biotech
Healthcare
Novel treatment options in cancer supportive care
Pharmaceuticals
PiroGon
Healthcare | AI
MedConnect AI Solutions
Healthcare
AlignRight: Future of Dental and Postural Health
Healthcare | IT&Technology | AI
Dynamic Tethering System for Scoliosis
Healthcare | Manufacturing

Activity Schedule

18:00
Welcome Сoffee. Registration.
Checking the sound and video. After the registration, you can take part in an informal conversation with other registered participants. To make the meeting atmosphere easy and enjoyable for you please take a cup of aromatic coffee with you to the monitor. Beautiful cups are welcome:-)
18:15
Round table discussion
What investment strategies should VCs adopt to navigate economic downturns while still backing innovation in healthcare?
19:05
PiroGon Presentation
PiroGon has developed an innovative AI-backed multi-indication neuro-modulation technology with a clear & well-defined path to success with clinical traction, regulatory clarity, platform potential with multi-indication neuromodulation, strong reimbursement tailwinds, marquee strategic interest to Detect, Diagnose and Train the muscles of the throat and the esophagus to stop Aspiration induced lung damage.
19:10
MyBone Presentation
Cerhum is a company bringing innovation to maxillofacial surgery with highly osteoconductive, patient-specific bioceramic bone grafts.
19:15
Arphamid Therapeutics Presentation
Arphamid Therapeutics is a Swiss/French biotech startup company aiming to improve the lives of cancer patients by delivering novel solutions for optimized cancer supportive care.
19:20
Accufix Presentation
Accufix is a specialty orthopedic device developer and distributor of The Accu-Joint® Hemi implant system — a revolutionary, FDA-approved treatment for MTP joint disorders that is designed to restore natural motion and preserve your active lifestyle.
19:25
Equaly Presentation
Equaly is a discovery-stage biotechnology company, dedicated to leverage the role of a newly discovered type of Natural Killer T (“NKT”) cells to propose an innovative immunological approach to fight and eliminate tumour cells.
19:30
One-on-One Meetings
All participants will have the opportunity to conduct brief introductory meetings with each other in small groups of 3 people. We will arrange 3 rounds 25 minutes each. The aim of these meetings is to get acquainted, learn interesting facts about each other. These are not negotiations - the aim is to simply get to know each other.
20:55
End of the Day
G.I.L.C. Monthly Chronicles
Receive a monthly delivery of exclusive articles, industry-specific insights and viewpoints from global investors. All tailored to help you make informed investment decisions.
Subscribe now
Join the community
Establish and expand trustful relationships with investment leaders in all regions of the world.
Explore unlimited investment opportunities, get access to first hand information,markets and capital. Enjoy the most effective high-end investment networking on Gilc.Club.
Join now
© 2023